Nalls Sherbakoff Group, LLC Novartis Ag Transaction History
Nalls Sherbakoff Group, LLC
- $112 Billion
- Q4 2023
A detailed history of Nalls Sherbakoff Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Nalls Sherbakoff Group, LLC holds 250 shares of NVS stock, worth $24,775. This represents 0.02% of its overall portfolio holdings.
Number of Shares
250
Previous 250
-0.0%
Holding current value
$24,775
Previous $25.5 Million
0.87%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,438Shares Held
133MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.21 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.19 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$802 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$692 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$572 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $213B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...